Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Inventory (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Inventory over the past 15 years, most recently at $32.3 million for Q2 2025.

  • For Q2 2025, Inventory fell 19.23% year-over-year to $32.3 million; the TTM value through May 2025 reached $32.3 million, down 19.23%, while the annual FY2025 figure was $32.3 million, 19.23% down from the prior year.
  • Inventory for Q2 2025 was $32.3 million at Lifecore Biomedical, Inc. \De\, down from $34.6 million in the prior quarter.
  • Over five years, Inventory peaked at $42.0 million in Q1 2023 and troughed at $31.4 million in Q1 2021.
  • A 5-year average of $37.8 million and a median of $38.8 million in 2022 define the central range for Inventory.
  • On a YoY basis, Inventory climbed as much as 27.53% in 2021 and fell as far as 53.11% in 2021.
  • Year by year, Inventory stood at $39.7 million in 2021, then decreased by 3.26% to $38.4 million in 2022, then increased by 7.88% to $41.4 million in 2023, then fell by 5.39% to $39.2 million in 2024, then fell by 17.65% to $32.3 million in 2025.
  • Business Quant data shows Inventory for LFCR at $32.3 million in Q2 2025, $34.6 million in Q1 2025, and $39.2 million in Q4 2024.